HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account

AML News

The HealthTree News for AML is a place to learn all about AML in easy-to-understand language. The site features news articles, patient stories, AML basics articles, and clinical trial updates with new content every week.

Transplant Recipients, Stay on Top of Your GI Screenings

Feb. 06, 2023

Transplant Recipients, Stay on Top of Your GI Screenings

Childhood AML - Learn About the Basics

Feb. 01, 2023

Childhood AML - Learn About the Basics

ASH 2022: Root Causes of Health Inequity

Jan. 30, 2023

ASH 2022: Root Causes of Health Inequity

ASH 2022: New Therapies in AML with Dr. Stein

Jan. 25, 2023

ASH 2022: New Therapies in AML with Dr. Stein

ASH 2022: Determining Who Does Well on Venetoclax and Azacitidine in Newly Diagnosed AML with Dr. Pollyea

Jan. 19, 2023

ASH 2022: Determining Who Does Well on Venetoclax and Azacitidine in Newly Diagnosed AML with Dr. Pollyea

ASH 2022: An Individualized Approach to Treating AML Patients with Dr. Becker

Jan. 12, 2023

ASH 2022: An Individualized Approach to Treating AML Patients with Dr. Becker

ASH 2022: Is a Restrictive Diet Necessary Post Stem Cell Transplant?

Jan. 04, 2023

ASH 2022: Is a Restrictive Diet Necessary Post Stem Cell Transplant?

What AML Taught Me in 2022

Jan. 01, 2023

What AML Taught Me in 2022

ASH 2022: A New Venetoclax Combination Therapy for Untreated AML and High-Risk MDS

Dec. 29, 2022

ASH 2022: A New Venetoclax Combination Therapy for Untreated AML and High-Risk MDS

ASH 2022: Treatment vs Quality of Life in Older AML Patients

Dec. 19, 2022

ASH 2022: Treatment vs Quality of Life in Older AML Patients

ASH 2022: Complete Response Criteria in Pediatric AML Needs Updating

Dec. 19, 2022

ASH 2022: Complete Response Criteria in Pediatric AML Needs Updating

ASH 2022: Revumenib Leads to Long-Lasting Responses in KMT2Ar(MLLr) and NPM1-Mutated AML

Dec. 14, 2022

ASH 2022: Revumenib Leads to Long-Lasting Responses in KMT2Ar(MLLr) and NPM1-Mutated AML

Recent Articles

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
AbbVie
Amgen
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube